MedTrace Logo

Adaptive Immune Response to Seasonal Influenza Vaccination (AIGI)

NCT05129436 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2023-10-03

No results posted yet for this study

Summary

AIGI (Adaptive Immune Response to Seasonal Influenza Vaccination) is a prospective clinical study aiming at studying the kinetics of vaccine-specific antibody production after seasonal influenza vaccination in health care workers.

Conditions

  • Seasonal Influenza Vaccination

Interventions

DRUG

Vaxigrip Tetra 2020/2021

vaccine against seasonal influenza

Sponsors & Collaborators

  • University Medicine Greifswald

    lead OTHER

Principal Investigators

  • Barbara M. Bröker, Prof. Dr. · University Medicine Greifswald, Dept. of Immunology

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-10-10
Primary Completion
2021-03-31
Completion
2023-12-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05129436 on ClinicalTrials.gov